相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Toward Optimization of Postremission Therapy for Residual Disease-Positive Patients With Acute Myeloid Leukemia
Luca Maurillo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Myeloid malignancies: Myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia
Brent L. Wood
CLINICS IN LABORATORY MEDICINE (2007)
Evaluation of complete disease remission in acute myeloid leukemia - A prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia
U Bacher et al.
CANCER (2006)
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia:: Results from cancer and leukemia group B study 8461
G Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
JF San Miguel et al.
BLOOD (2001)